Sarnak MJ - Search Results

1

More Evidence to Suggest a Relation of Blood Pressure to Long-term Progression of Kidney Disease: Is It Causal?

McCallum W, Ku E, Sarnak MJ. McCallum W, et al. Among authors: sarnak mj. Am J Kidney Dis. 2019 Sep;74(3):293-296. doi: 10.1053/j.ajkd.2019.05.004. Epub 2019 Jun 27. Am J Kidney Dis. 2019. PMID: 31257049 Free PMC article. No abstract available.

2

Cardiovascular disease and chronic renal disease: a new paradigm.

Sarnak MJ, Levey AS. Sarnak MJ, et al. Am J Kidney Dis. 2000 Apr;35(4 Suppl 1):S117-31. doi: 10.1016/s0272-6386(00)70239-3. Am J Kidney Dis. 2000. PMID: 10766010

3

Homocysteine, cysteine, and B vitamins as predictors of kidney disease progression.

Sarnak MJ, Wang SR, Beck GJ, Kusek JW, Selhub J, Greene T, Levey AS. Sarnak MJ, et al. Am J Kidney Dis. 2002 Nov;40(5):932-9. doi: 10.1053/ajkd.2002.36323. Am J Kidney Dis. 2002. PMID: 12407637 Clinical Trial.

4

Cardiovascular complications in chronic kidney disease.

Sarnak MJ. Sarnak MJ. Am J Kidney Dis. 2003 Jun;41(5 Suppl):11-7. doi: 10.1016/s0272-6386(03)00372-x. Am J Kidney Dis. 2003. PMID: 12776309 Review.

5

Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease.

Menon V, Wang X, Greene T, Beck GJ, Kusek JW, Marcovina SM, Levey AS, Sarnak MJ. Menon V, et al. Among authors: sarnak mj. Am J Kidney Dis. 2003 Jul;42(1):44-52. doi: 10.1016/s0272-6386(03)00407-4. Am J Kidney Dis. 2003. PMID: 12830455

6

Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials.

Alonso A, Lau J, Jaber BL, Weintraub A, Sarnak MJ. Alonso A, et al. Among authors: sarnak mj. Am J Kidney Dis. 2004 Jan;43(1):1-9. doi: 10.1053/j.ajkd.2003.09.009. Am J Kidney Dis. 2004. PMID: 14712421

7

Kidney disease as a risk factor for recurrent cardiovascular disease and mortality.

Weiner DE, Tighiouart H, Stark PC, Amin MG, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ. Weiner DE, et al. Among authors: sarnak mj. Am J Kidney Dis. 2004 Aug;44(2):198-206. doi: 10.1053/j.ajkd.2004.04.024. Am J Kidney Dis. 2004. PMID: 15264177

8

Factors associated with lipoprotein(a) in chronic kidney disease.

Uhlig K, Wang SR, Beck GJ, Kusek JW, Marcovina SM, Greene T, Levey AS, Sarnak MJ. Uhlig K, et al. Among authors: sarnak mj. Am J Kidney Dis. 2005 Jan;45(1):28-38. doi: 10.1053/j.ajkd.2004.08.043. Am J Kidney Dis. 2005. PMID: 15696441

9

The epidemiology of chronic kidney disease stages 1 to 4 and cardiovascular disease: a high-risk combination.

Menon V, Sarnak MJ. Menon V, et al. Among authors: sarnak mj. Am J Kidney Dis. 2005 Jan;45(1):223-32. doi: 10.1053/j.ajkd.2004.09.022. Am J Kidney Dis. 2005. PMID: 15696466 No abstract available.

10

The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study.

Sarnak MJ, Greene T, Wang X, Beck G, Kusek JW, Collins AJ, Levey AS. Sarnak MJ, et al. Ann Intern Med. 2005 Mar 1;142(5):342-51. doi: 10.7326/0003-4819-142-5-200503010-00009. Ann Intern Med. 2005. PMID: 15738453 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

442 results

Search Page

Filters